NCT03067415

Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily

A Multi Center, Randomized, Double-blind, Parallel Design, Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily in Primary Open Angle Glaucoma or Ocular Hypertension Patients.

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 98 (estimated)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Exploratory trial to evaluate the efficacy and safety of D565H twice daily versus D565 once daily.

Detailed description

A Multi center, Randomized, Double-blind, Parallel design, Exploratory trial to evaluate the efficacy and safety of D565H twice daily versus D565 once daily in primary open angle glaucoma or ocular hypertension patients.

Conditions

• Glaucoma, Primary Open Angle
• Ocular Hypertension

Interventions

Type	Name	Description
DRUG	D565H(Latanoprost 25㎍/㎖)	D565H twice daily
DRUG	D565(Latanoprost 50㎍/㎖)	D565 once daily

Timeline

• Start date: 2017-03-30
• Primary completion: 2017-09-10
• Completion: 2017-09-30
• First posted: 2017-03-01
• Last updated: 2017-07-21

Locations

1 site across 1 country: South Korea